Pharmacoeconomic Impact and Transplant Outcome Associated to Carmustine (BCNU) Substitution with Bendamustine (Be) in the Conditioning Regimen Prior to Autologous Stem Cell Transplantation for Lymphoma Treatment

被引：0
|
作者：
Boisjoly, Josie-Anne [1 ]
Bouchard, Philippe [2 ]
Ahmad, Imran [3 ]
Bambace, Nadia M. [3 ]
Bernard, Lea [3 ]
Cohen, Sandra [3 ]
Delisle, Jean-Sebastien [3 ]
Kiss, Thomas L. [4 ]
Roy, Denis-Claude [3 ]
Sauvageau, Guy [3 ]
Roy, Jean [3 ]
Lachance, Silvy [3 ]
机构：
[1] Ctr Hosp Univ Sherbrooke, Div Hematol Oncol, Sherbrooke, PQ, Canada
[2] Univ Montreal, Hop Maisonneuve Rosemont, Pharm, Montreal, PQ, Canada
[3] Univ Montreal, Hop Maisonneuve Rosemont, Div Hematol Oncol & Transplantat, Montreal, PQ, Canada
[4] Univ Montreal, Hop Maisonneuve Rosemont, Hematol Oncol & Hematopoiet Cell Transplantat, Montreal, PQ, Canada
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
155
引用
收藏
页码：S129 / S130
页数：2
相关论文
共 50 条
  • [1] Impact of Carmustine (BCNU) Substitution for Bendamustine in the Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation for the Treatment of Lymphoma
    Boisjoly, Josie-Anne
    Bouchard, Philippe
    Cohen, Sandra
    Ahmad, Imran
    Bambace, Nadia M.
    Bernard, Lea
    Delisle, Jean-Sebastien
    Kiss, Thomas L.
    Roy, Denis-Claude
    Sauvageau, Guy
    Roy, Jean
    Lachance, Silvy
    BLOOD, 2017, 130
  • [2] Conditioning regimen with cisplatin (PEAM) versus carmustine-BCNU (BEAM) followed by autologous haematopoietic stem cell transplantation in lymphoma
    Padilla-Ortega, J. A.
    Acosta-Maldonado, B. L.
    Rivera-Fong, L.
    Zazueta-Pozos, J. F.
    Ladines-Castro, W. J.
    Dulon-Tarqui, J. E.
    Valero-Saldana, L. M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S324 - S325
  • [3] Comparison of Safety and Efficacy of Bendamustine versus Carmustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractoy lymphoma
    Moosajee, Munira
    Jehangir, Samad
    Sawani, Sobia
    Tariq, Wajeeha
    Ali, Natasha
    Sheikh, Mohammed Usman
    Adil, Salman
    BONE MARROW TRANSPLANTATION, 2018, 53 : 269 - 269
  • [4] Bendamustine as an alternative to BCNU as conditioning regimen for autologous stem cell transplantation in patients with aggressive lymphoma: Results phase 2 study from GELTAMO
    Maria Redondo, Alba
    Valcarcel, D.
    Gonzalez, A. P.
    Suarez-Lledo, M.
    Bello, J. L.
    Canales, M.
    Gayoso, J.
    Conde, E.
    Jarque, I.
    Del Campo, R.
    Arranz, R.
    Terol, M. J.
    Rifon, J. J.
    Rodriguez, M. J.
    Ramirez, M. J.
    Castro, N.
    Sanchez, A.
    Lopez-Jimenez, J.
    Briones, J.
    Lopez, A.
    Palomera, L.
    Baile, M.
    Caballero, Dolores
    Martin, Alejandro
    BONE MARROW TRANSPLANTATION, 2018, 53 : 261 - 262
  • [5] Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma
    Shabbir-Moosajee, Munira
    Jehangir, Samad
    Sawani, Sobiya
    Muhammed, Tariq
    Ali, Natasha
    Sheikh, Usman
    Adil, Salman
    BLOOD RESEARCH, 2019, 54 (02) : 108 - 113
  • [6] Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma
    Scortechini, Ilaria
    Montanari, Mauro
    Mancini, Giorgia
    Inglese, Elena
    Calandrelli, Monica
    Chiarucci, Martina
    Offidani, Massimo
    Capelli, Debora
    Gini, Guido
    Poloni, Antonella
    Mancini, Stefania
    Raggetti, Gianmario
    Leoni, Pietro
    Olivieri, Attilio
    LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1657 - 1660
  • [7] Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge
    Lachance, Sylvie
    Bourguignon, Alex
    Boisjoly, Josie-Anne
    Bouchard, Philippe
    Ahmad, Imran
    Bambace, Nadia
    Bernard, Lea
    Cohen, Sandra
    Delisle, Jean-Sebastien
    Fleury, Isabelle
    Kiss, Thomas
    Mollica, Luigina
    Roy, Denis-Claude
    Sauvageau, Guy
    Veilleux, Olivier
    Zehr, Justine
    Chagnon, Miguel
    Roy, Jean
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (01): : 34.e1 - 34.e7
  • [8] Outcome of CBV (Carmustine, Cyclophosphamide, Etoposide) Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma: A Retrospective Study from a Tertiary Cancer Center in South India
    Krishnamoorthi, Narendran
    Prakash, Bhanu
    Dhanraju, K. M.
    Pani, Chinmaya Kumar
    Ram, Malliha
    Rajesh, Kalpana
    Dubashi, Biswajit
    Ganesan, Prasanth
    Kayal, Smita
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2022,
  • [9] BORTEZOMIB AND BEAM CONDITIONING REGIMEN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN MANTLE CELL LYMPHOMA
    Hebraud, B.
    Roussel, M.
    Ysebaert, L.
    Gaudin, C.
    Laurent, G.
    Attal, M.
    Huynh, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 462 - 463
  • [10] MODIFIED BEAM SCHEDULE WITH LOMUSTINE INSTEAD OF CARMUSTINE IN THE CONDITIONING REGIMEN OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN LYMPHOMA PATIENTS: ANALYSIS OF EFFICACY AND TOXICITY
    Terruzzi, E.
    Parma, M.
    Fedele, M.
    Diral, E.
    Brambilla, C.
    Aroldi, A.
    Gambacorti-Passerini, C.
    Pioltelli, P.
    HAEMATOLOGICA, 2017, 102 : 143 - 143
12345